Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E A Harper

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
British Journal of Pharmacology|August 1, 1996
Analysis of variation in L-365,260 competition curves in radioligand binding assaysE A Harper, S P Roberts, N P Shankley, et al.
British Journal of Pharmacology|September 12, 2003
Pharmacological comparison of the alternatively spliced short and long CCK2 receptorsM F Morton, E A Harper, I A Tavares, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|June 20, 2001
Comparison of ligand affinity values at the recombinant human H3 receptor and at H3 receptor(s) of human cingulate cortexE A Harper, T W Lovenberg, N P Shankley, et al.
Lancet (London, England)|October 30, 1982
Serratia marcescens pseudobacteremia on a special care baby unitK N Ives, N A Evans, B T Thom, et al.
British Journal of Pharmacology|April 27, 1999
Analysis of the behaviour of selected CCKB/gastrin receptor antagonists in radioligand binding assays performed in mouse and rat cerebral cortexE A Harper, E P Griffin, N P Shankley, et al.
British Journal of Pharmacology|July 12, 2002
Pharmacological evidence for putative CCK(1) receptor heterogeneity in human colon smooth muscleM F Morton, E A Harper, I A Tavares, et al.
British Journal of Pharmacology|March 1, 1993
2-Naphthalenesulphonyl L-aspartyl-(2-phenethyl)amide (2-NAP)--a selective cholecystokinin CCKA-receptor antagonistR A Hull, N P Shankley, E A Harper, et al.
Bioorganic & Medicinal Chemistry Letters|July 16, 1999
From histamine to imidazolylalkyl-sulfonamides: the design of a novel series of histamine H3-receptor antagonistsM J Tozer, E A Harper, S B Kalindjian, et al.
Annals of Clinical and Laboratory Science|March 26, 1998
Chromosome 6 abnormalities associated with prolymphocytic acceleration in chronic lymphocytic leukemiaA B Glassman, E A Harper-Allen, K J Hayes, et al.
British Journal of Pharmacology|August 1, 1996
Analysis of the variation in the action of L-365,260 at CCKB/gastrin receptors in rat, guinea-pig and mouse isolated gastric tissue assaysS P Roberts, E A Harper, G F Watt, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
British Journal of Pharmacology|August 1, 1996
Analysis of variation in L-365,260 competition curves in radioligand binding assaysE A Harper, S P Roberts, N P Shankley, et al.
British Journal of Pharmacology|September 12, 2003
Pharmacological comparison of the alternatively spliced short and long CCK2 receptorsM F Morton, E A Harper, I A Tavares, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|June 20, 2001
Comparison of ligand affinity values at the recombinant human H3 receptor and at H3 receptor(s) of human cingulate cortexE A Harper, T W Lovenberg, N P Shankley, et al.
Lancet (London, England)|October 30, 1982
Serratia marcescens pseudobacteremia on a special care baby unitK N Ives, N A Evans, B T Thom, et al.
British Journal of Pharmacology|April 27, 1999
Analysis of the behaviour of selected CCKB/gastrin receptor antagonists in radioligand binding assays performed in mouse and rat cerebral cortexE A Harper, E P Griffin, N P Shankley, et al.
British Journal of Pharmacology|July 12, 2002
Pharmacological evidence for putative CCK(1) receptor heterogeneity in human colon smooth muscleM F Morton, E A Harper, I A Tavares, et al.
British Journal of Pharmacology|March 1, 1993
2-Naphthalenesulphonyl L-aspartyl-(2-phenethyl)amide (2-NAP)--a selective cholecystokinin CCKA-receptor antagonistR A Hull, N P Shankley, E A Harper, et al.
Bioorganic & Medicinal Chemistry Letters|July 16, 1999
From histamine to imidazolylalkyl-sulfonamides: the design of a novel series of histamine H3-receptor antagonistsM J Tozer, E A Harper, S B Kalindjian, et al.
Annals of Clinical and Laboratory Science|March 26, 1998
Chromosome 6 abnormalities associated with prolymphocytic acceleration in chronic lymphocytic leukemiaA B Glassman, E A Harper-Allen, K J Hayes, et al.
British Journal of Pharmacology|August 1, 1996
Analysis of the variation in the action of L-365,260 at CCKB/gastrin receptors in rat, guinea-pig and mouse isolated gastric tissue assaysS P Roberts, E A Harper, G F Watt, et al.
Pageof 3